SS-31, is a novel mitochondria-targeted antioxidant peptide.
- Mitochondrial Function and ATP Synthesis: SS-31 has been studied for its ability to improve mitochondrial function. Mitochondria are the energy-producing organelles in cells, and SS-31 is designed to target them specifically. By enhancing mitochondrial function, SS-31 contributes to the production of adenosine triphosphate (ATP), the primary energy currency of cells.
- Reduction of Inflammatory Cytokines: Research suggests that SS-31 has anti-inflammatory properties. It has been shown to reduce the levels of inflammatory cytokines, which are signaling molecules involved in the inflammatory response. Chronic inflammation is implicated in various diseases, including neurodegenerative conditions like Alzheimer’s and Parkinson’s, as well as cardiovascular diseases, diabetes, and kidney diseases.
- Oxidative Stress Mitigation: SS-31’s antioxidant properties contribute to reducing oxidative stress. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body’s ability to neutralize them. Oxidative stress is linked to various diseases, and by mitigating it, SS-31 may have protective effects on cells and tissues.





